Ventrus executes a reverse merger with subsidiary

Ventrus Biosciences (VTUS) merges with its wholly-owned subsidiary Assembly Acquisition (merger sub) and Assembly Pharmaceuticals. After the transaction, Assembly Acquisition will cease and Assembly Pharmaceuticals will survive as a wholly-owned subsidiary of Ventrus. Share of Assembly will be automatically converted into Ventrus shares at a specific exchange ratio (undisclosed).

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs